We are only able to display limited information for this firm. We display more complete information for all of the following firms:

Regularly handling director and shareholder disputes, Mishcon de Reya LLP boasts an active group litigation practice and a private commercial litigation team, led by the ‘extremely knowledgeable’ Janet Tobin and Victoria Pigott, ’a litigator of the highest calibre‘. Nicola Bridge leads the commercial litigation group and Richard Leedham is division head for commercial disputes, focusing his practice on insurance, representing individual clients and institutional funds in claims stemming from investments. Sanctions expert and ’true lead partner’ Shaistah Akhtar is another name to note, alongside Mark Davis. Andrew Short’s diverse clientele spans the financial services, healthcare, construction, technology and insurance sectors, while Tom Roberts’ balanced claimant and defendant practice encompasses breach of contract, negligence and fraud claims.
Legal 500 Editorial commentary

Testimonials

Collated independently by Legal 500 research team.

  • ‘Shaistah Akhtar. A litigator par excellence. She has an eye for the skills needed for each case. Once a team is assembled she manages it brilliantly, delegating to and trusting her highly effective team members and reserving for herself the critical client-facing tasks, key strategic decisions, and spotting the points otherwise missed. A pleasure to work with. Andrew Short. A brilliant Partner, miles ahead of his peers. Excellent in a pressured trial environment. Lydia Allenby - obvious Partner material. Incisive and a brilliant litigation mind, able to spot potential traps. A brilliant manager of the running of the case. Himaansu Servansingh - An incredibly efficient member of the team. Very sharp mind.’

  • 'A very strong, senior, female team in the private commercial litigation practice. They are very focused on finding the right solutions for their clients and the right third parties to work with them, where relevant.’

Key clients

  • Diag Human and Josef Stava
  • Various investors in the shares of Indivior plc and Reckitt Benckiser Group plc